共 284 条
[1]
Waugh J(2004)The paclitaxel (TAXUS)-eluting stent: a review of its use in the management of de novo coronary artery lesions Am J Cardiovasc Drugs 4 257-268
[2]
Wagstaff AJ(2007)Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization Circulation 115 2435-2441
[3]
Finn AV(2006)Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 193-202
[4]
Joner M(2008)2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines J Am Coll Cardiol 51 172-209
[5]
Nakazawa G(2004)Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis Circulation 110 810-814
[6]
Kolodgie F(2009)Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis Circulation 119 2986-2994
[7]
Newell J(2006)Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter N Engl J Med 355 2113-2124
[8]
John MC(2008)Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter Clin Res Cardiol 97 773-781
[9]
Gold HK(2009)Drug-eluting balloon. The comeback kid? Circ Cardiovasc Interven 2 352-358
[10]
Virmani R(2008)Hotline update of clinical trials and registries presented at the German Cardiac Society meeting 2008 (PEPCAD LokalTax, INH, German ablation registry, German device registry, DESDE registry, DHR, Reality, SWEETHEART registry, ADMA, GERSHWIN) Clin Res Cardiol 97 356-363